Similar Articles

Browse Main Topics:

Business
Computers & Electronics
Education & Reference
Entertainment & Leisure
Family & Home
Finance & Investment
Health
Internet
Pets & Animals
Science & Technology
Society, Politics & Culture
Sports & Recreation

Similar Articles

HHMI Bulletin Aug 2011	Seeing is Believing Today, researchers are finding clever ways to deliver long-lasting, healthy genes without triggering a serious immune response.
Salon.com June 1, 2000 Tabitha M. Powledge	Gene therapy R.I.P.? When the country's biggest gene therapy institute was ordered to stop testing on humans last week, the action marked the end of an era fraught with dubious claims to success and a mess of unreported adverse effects.
The Motley Fool July 30, 2007 Brian Orelli	Another Blow to Gene Therapy The FDA shuts down a clinical trial, tripping up Targeted Genetics and possibly its competitors. A subject in the trial of their gene therapy arthritis medication died shortly after taking the drug.
BusinessWeek April 22, 2010 Rob Waters	Gene Therapy Takes a Turn for the Better Researchers and investors are heartened by advances in gene therapy. Analysts say revenues are still several years off, however.
Reason October 2007 Ronald Bailey	Ties That Bind Considering that thousands of clinical trials are undertaken every year, it's reassuring that the pharmaceutical industry's critics can turn up only a few instances of bad behavior caused by financial conflicts of interest during the last two decades.
BusinessWeek February 10, 2011 Rob Waters	Sangamo's Bet Against AIDS: Gene Therapy Sangamo's stock has more than doubled since July 6, when the company, with no products on the market, reported success of its gene therapy approach in mice in the journal Nature Biotechnology.
AskMen.com Joshua Levine	Selling Your Body To Science Have you ever thought about the number of voluntary patients who basically sell their bodies to clinical trials in the name of science? Well, the number is staggering and it can reach well into the thousands. The main reason being the large paycheck that comes with the job.
Fast Company December 2009 Elizabeth Svoboda	Biotechs Look Overseas to Launch a Stem-Cell Revolution According to one small biotech, the best way to launch a stem-cell revolution is to do it overseas.
Chemistry World November 5, 2012 Andrew Turley	Approval for first gene therapy drug Alipogene tiparvovec, marketed as Glybera, has become the first gene therapy drug to win approval in either the US or the EU.
The Motley Fool August 2, 2010 Brian Orelli	Back in Love With Geron Investors' love / hate relationship with Geron is back in the worship phase, with the stem cells company up 17% on Friday and nearly an additional 10% or so today.
Chemistry World April 9, 2015 Emma Stoye	BMS invests in gene therapy Bristol-Myers Squibb has agreed to invest over $100 million in Netherlands-based biotechnology company uniQure, which specializes in gene therapies for cardiovascular diseases.
Pharmaceutical Executive July 1, 2011 Dickmeyer & Rosenbeck	From Rut to Racetrack Can the pharmaceutical industry deliver on its objective to make cancer a curable, chronic condition?
Salon.com September 28, 2000 Arthur Allen	Bioethics comes of age A lawsuit blaming the nation's most prominent bioethicist for the death of an 18-year-old prompts a reexamination of the field...
Salon.com August 18, 2000 Arthur Allen	Tainted alliances Are doctors shilling for drug companies?
Wired September 2002 Amanda Griscom	Take These Genes and Call Me in the Morning Gene vaccines may be relatively new, but they're the logical outgrowth of two familiar strands of medical science.
BusinessWeek March 6, 2006 Bruce Einhorn	A Cancer Treatment You Can't Get Here China, with lower regulatory hurdles, is racing to a lead in gene therapy.
Reason April 2007 Ronald Bailey	Testing Your Strength The World Anti-Doping Agency is developing tests for a form of cheating that doesn't exist yet. The agency banned gene doping, the alteration of genes to enhance athletic performance.
Chemistry World February 24, 2010 James Urquhart	Buckyball-based gene delivery Japanese researchers have demonstrated effective gene delivery in mice using carbon buckyballs.
Bio-IT World October 10, 2003 Donna Mendrick	Microarrays That Make Drugs Safe Using DNA chips to discover potential toxicity in new drug compounds -- a key application of toxicogenomics -- can predict adverse effects before they occur, enabling safer clinical trials.
Fast Company March 2006 Ramez Naam	The Body: Bulletproof Gene therapy is on its way - and it's coming fast.
Scientific American July 2008 Christine Soares	Looking at Yesterday's Genes for Tomorrow's Cures Resurrected "jumping gene" could deliver DNA.
CIO March 15, 2006 Allan Holmes	Rx for Risk As it revamps its workflow processes, the FDA is relying on technology to reduce the risk that unsafe substances will get into the market.
Salon.com December 19, 2000 Carolyn McConnell	"The Century of the Gene" by Evelyn Fox Keller A new book argues that there may be no such thing as a gene. At least, it has proved very difficult to isolate a discrete physical item that can do the work our notion of the gene does...
Smithsonian November 2005 Robert Wright	35 Who Made a Difference: Edward O. Wilson Someday, Wilson believes, the cause-and-effect principles of psychology will rest solidly and specifically on those of biology, which will rest with equal security on principles of biochemistry and molecular biology, and so on down the line to particle physics.
Popular Mechanics April 15, 2009 Erin McCarthy	Is Fringe's Genetic Monster Possible? Unlike the monster on Fringe, altered animals typically have only a single gene difference from non-altered animals -- but they can look different.
Outside January 2006 Ryan Brandt	The Daredevil Gene Fear for your life every time the surf picks up? Blame your heredity.
Bio-IT World March 8, 2005 Kevin Davies	Evolution of New Genes Studied EMBL researchers use comparative genomic analysis to identify new primate-specific gene family.
Salon.com May 1, 2000 Arthur Allen	Listening to DNA The genome project is getting the buzz. But the real breakthroughs may come from labs out of the limelight, like Gene Logic.
American Family Physician November 1, 2006 Lurie et al.	Seasonal Affective Disorder Patients with seasonal affective disorder have episodes of major depression that tend to recur during specific times of the year, usually in winter. Like major depression, seasonal affective disorder probably is underdiagnosed in primary care settings.
Bio-IT World March 10, 2003 Salvatore Salamone	Common Knowledge Two heads (or more) are better than one, except when they don't share information. That's where knowledge management comes in.
Bio-IT World June 2006 Kevin Davies	The Data Deluge: Deal or No Deal? Far from decrying the data glut, researchers should embrace the complexity of genomic and other sources of data, particularly for its predictive properties in the field of personalized medicine.
InternetNews September 7, 2004 Clint Boulton	IBM's Blue Gene Breaks New Research Ground The four-rack supercomputer system will map protein structures in the hope of manufacturing more effective drugs for humans.
American Family Physician January 1, 2006 Rupke, Blecke & Renfrow	Cognitive Therapy for Depression Family physicians usually are the first to diagnose and treat patients with depression. They should inform patients that psychotherapy and pharmacotherapy are valid options, and that cognitive therapy is the most studied psychotherapy.
Pharmaceutical Executive February 1, 2006 Ron Feemster	Gene Logic: Rescue Squad One or two late-stage clinical failures can land promising drug candidates on the shelf. Forever? Maybe not. Gene Logic tests Big Pharma's dead drugs for hundreds of different targets.
Wired February 25, 2008 Julie Sloane	15th Anniversary: DNA-Customized Medicine Still Stuck in the Pipeline Gene scanning isn't yet standard practice. But over the past six years, medicine has been inching closer to prescriptions that are custom-matched to a patients' DNA.
BusinessWeek June 13, 2005 John Carey	The NIH's Roadmap for Research Charting the human genome was just the beginning. Now the focus is creating pathways that will lead to practical applications.
Bio-IT World October 14, 2004 William Pulleyblank	Rewriting the Rulebook for Supercomputing and Research IBM's Blue Gene supercomputer project leader highlights progress and future applications.
AskMen.com October 30, 2013 Michelle Magnan	The Difference Between Usain Bolt And You: The point that David Epstein explores at length in The Sports Gene, is that no two people respond to sports training the same way, because no two genomes are the same.
Chemistry World July 29, 2015 Phillip Broadwith	Biogen to develop gene therapies with AGTC The deal covers AGTC's development programs for several rare eye diseases using a viral-based gene delivery vector.
Bio-IT World Dec 2006/Jan 2007 Kevin Davies	The NextBio Thing in Bioinformatics NextBio, which this fall officially introduced its platform after a year of beta testing by a handful of select organizations, aims to provide high-throughput information to researchers without them having to learn anything.